Used primarily in the pharmaceutical industry, this compound serves as a key intermediate in the synthesis of various sulfonamide-based drugs. Its sulfamoyl group makes it valuable for developing medications with antibacterial and diuretic properties. It is also employed in research settings to study enzyme inhibition, particularly targeting carbonic anhydrase, which is relevant in treating conditions like glaucoma and epilepsy. Additionally, its derivatives are explored for potential anti-inflammatory and anticancer applications.